Professor Jonathan M. Gibson MB BS, MD, FRCSEd, FRCOphth

• 1971-1976: Medical College of St.Bartholomew’s Hospital, University of London.
• 1977-1978: Pre-registration house jobs in London and Edinburgh.
• 1978-1981: Senior House Office and Registrar in Ophthalmology, Princess Alexandra Eye Pavilion, Royal Infirmary Edinburgh.
• 1981-1986: Lecturer/Hon.Senior Registrar in Ophthalmology, University of Leicester and Leicester Royal Infirmary
• 1986-2011: Consultant Ophthalmic Surgeon, Birmingham and Midland Eye Centre, Sandwell & West Birmingham NHS Trust.
• 1986-current: Consultant Ophthalmologist Birmingham Heartlands and Solihull Hospitals, Heart of England Foundation Trust 
• 1990-current: Honorary Senior Lecturer, University of Birmingham Medical School
• 2007-2017: Personal Chair in Ophthalmology, Aston University
• 2017-Current Emeritus Professor, Aston University
  

• 1976 Bachelor of Medicine, Bachelor of Surgery,  St Bartholomew's Hospital, University of London
• 1981 Fellow of the Royal College of Surgeons, Edinburgh
• 1987 MD University of Leicester

• 1989 Fellow of the Royal College of Ophthalmologists

• 2005-current: Silver (Level 10) Clinical Excellence Award

• 2009-2010: Macular Disease Society – Joint Inaugural Winner best clinical service (BMEC)

Third Year Undergraduate

• Hospital Ophthalmology Clinical Teaching

• Diabetic Retinopathy Screening Module

• Aston Ophthalmology Referral Clinic (with Dr. Doina Gherghel)

Ophthalmic Doctorate

• Retina and Macula Module (With Dr. Hannah Bartlett)

• Imaging of the human fundus – collaboration: Dr. Antonio Calcagni, Professor Ela Claridge, Dr.Iain Styles, University of Birmingham.

• Age related macular degeneration

• Diabetic retinopathy – collaboration Professor Paul Dodson, Heart of England NHS Foundation Trust;

• Retinal vascular disorders

• European Vision Institute Clinical Trials Network -; Collaborator Prof. Jose Cunha Vaz, Coimbra, Portugal.

• Enhanced Vision Programme -: Collaboration Professor Yit Yang Wolverhampton, Professor Victor Chong Oxford, Dr.Jennifer Acton ,Columbia University, New York.

• 1997-2003: Member of Council, The Royal College of Ophthalmologists, London

• 2001-2002: Director of Research and Development, Heartlands Solihull NHS Trust

• 2001-2002: Past President Midland Ophthalmological Society

• 1995-2001: Regional Adviser in Ophthalmology, Royal College Surgeons, Edinburgh.

• 1993-2009: Examiner in Ophthalmology, Royal College Surgeons, Edinburgh

• 1991- current: Examiner for Royal College of Ophthalmologists

• 2003-2006: Chairman Solihull Division, British Medical Association.

• 2005-2008: College Tutor, Royal College of Ophthalmologists

• 1997-2004: Overseas examiner, FRCSEd Ophthalmology Saudi Arabia and India and Bahrein.

• 2010-current: Co- Chair Birmingham and Black Country CLRN Research Network Ophthalmology and Vision Science

• 2003-2005: Co grant holder with Professor Ela Claridge, Birmingham University, of EPSRC Grant for £120k to investigate and develop and new means of fundus imaging interpretation.

• 2003- 2008: Principal Investigator at BMEC, Cohort Study of Verteporfin -PDT laser in AMD. Sponsor ; NHS

• 2004-2006: Principal Investigator Anecortave Acetate Trial in AMD

• 2005-2007: Principal Investigator,EXCITE and SECURE studies in AMD , sponsor Novartis

• 2008 – 2011: Principal Investigator , VIEW 2 Study of VEGF Trap in AMD, Aston University, Sponsor Bayer-Schwering..

• 2009-2011: Principal Investigator  unrestricted educational grant £29,000 “Teleophthalmology Project”; sponsor Novartis.

• 2008- current: Principal Investigator IVAN Trial at BMEC, sponsor MRC/NHS

• 2009- 2012: Co- investigator Aston/Birmingham Retinal Imaging Group -  Dunhill Charity “multispectral imaging of the fundus”  awarded £98,000

• 2011- current: Principal Investigator RET-2010 trial, at MIDRU HEFT NHS Trust, sponsor EVICR.Net

• 2011-current: Principal Investigator RELIGHT Study of Lucentis in DMO, at MIDRU, HEFT NHS Trust.  Sponsor Novartis

• 2011-current: Principal Investigator LUMINOUS Study, Sponsor Novartis.

• 2011-current: Principal Investigator, EuroCondor Study by EVICR.Net, EU FP7 Grant for €330,000.

• 2011-current: Collaborative study with Belfast – “assessment of preferential hyperacuity perimetry in monitoring of wet AMD Patients.” Unrestricted grant of £6,000 from Novartis.

• Fellow Royal College of Ophthalmologists
• Member British Medical Association
• Fellow Royal College of Surgeons of Edinburgh
• American Academy of Ophthalmology
• Midland Ophthalmological Society
• Medical Retina Group (Co-founder)
• Fellow Royal Society of Medicine